We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
AUM
$2.65B
AUM Growth
+$68.2M
Cap. Flow
+$105M
Cap. Flow %
3.99%
Top 10 Hldgs %
43.52%
Holding
66
New
14
Increased
16
Reduced
21
Closed
14

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$122M
2
ZBH icon
Zimmer Biomet
ZBH
+$96.2M
3
BAX icon
Baxter International
BAX
+$88.2M
4
BIIB icon
Biogen
BIIB
+$83.1M
5
LH icon
Labcorp
LH
+$80.4M

Sector Composition

Rank Sector Weight
1 Healthcare 90.28%
2 Technology 1.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
1
Edwards Lifesciences
EW
$50B
$138M 5.2%
1,877,970
+11,280
+0.6% +$792K
NBIX icon
2
Neurocrine Biosciences
NBIX
$18.7B
$135M 5.09%
1,493,480
-877,910
-37% -$82M
MRK icon
3
Merck
MRK
$321B
$131M 4.96%
1,633,088
+278,642
+21% +$22.3M
BIIB icon
4
CALL
Biogen
BIIB
$30.7B
$128M 4.84%
+550,000
New +$128M
ISRG icon
5
Intuitive Surgical
ISRG
$126B
$127M 4.8%
+705,615
New +$122M
VRTX icon
6
Vertex Pharmaceuticals
VRTX
$122B
$115M 4.35%
679,690
+141,250
+26% +$25M
ZBH icon
7
Zimmer Biomet
ZBH
$18.4B
$99.3M 3.75%
+745,071
New +$96.2M
DHR icon
8
Danaher
DHR
$138B
$99.2M 3.75%
774,913
+202,069
+35% +$25.3M
BAX icon
9
Baxter International
BAX
$13.8B
$90.3M 3.41%
+1,032,820
New +$88.2M
MDGL icon
10
Madrigal Pharmaceuticals
MDGL
$11.4B
$88.9M 3.36%
1,031,220
-1,050
-0.1% -$98.5K
UNH icon
11
UnitedHealth
UNH
$383B
$85.5M 3.23%
393,530
-3,910
-1% -$943K
CVRS
12
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$85.5M 3.23%
19,981,655
BIIB icon
13
Biogen
BIIB
$30.7B
$83.1M 3.14%
+356,860
New +$83.1M
NVRO
14
DELISTED
NEVRO CORP.
NVRO
$82M 3.1%
953,820
-273,910
-22% -$20.7M
LH icon
15
Labcorp
LH
$25.9B
$79.5M 3.01%
+551,131
New +$80.4M
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$71.6M 2.71%
2,628,840
-164,830
-6% -$4.26M
ABT icon
17
Abbott
ABT
$183B
$63.3M 2.39%
756,400
-387,760
-34% -$32.9M
MDT icon
18
Medtronic
MDT
$110B
$58.1M 2.2%
534,750
-43,550
-8% -$4.54M
BMY icon
19
Bristol-Myers Squibb
BMY
$132B
$56.7M 2.14%
1,117,710
-894,940
-44% -$42.1M
CHNG
20
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$51.4M 1.94%
4,254,430
+1,564,240
+58% +$21.5M
HCA icon
21
HCA Healthcare
HCA
$85.7B
$49M 1.85%
407,230
-12,100
-3% -$1.56M
CRL icon
22
Charles River Laboratories
CRL
$11.3B
$48.4M 1.83%
365,360
+947
+0.3% +$127K
BLUE
23
DELISTED
bluebird bio
BLUE
$46.6M 1.76%
39,147
+10,730
+38% +$16.4M
BPMC
24
DELISTED
Blueprint Medicines
BPMC
$44.8M 1.69%
609,417
+226,913
+59% +$19.6M
JNJ icon
25
Johnson & Johnson
JNJ
$617B
$44.4M 1.68%
+343,540
New +$45.3M

Similar funds

HealthCor Management's Q3 2019 Portfolio in Review

As of Q3 2019, HealthCor Management held 66 positions worth $2.65B, up 2.6% from $2.58B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

HealthCor Management deployed $105M of net new capital in Q3 2019, opening 14 new positions and adding to 16 existing holdings. Its largest new stake was Intuitive Surgical: 705,615 shares worth $127M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 91% a quarter earlier, followed by Technology.

On the sell side, the largest reduction was Humana, an estimated $161M trimmed.

  • HealthCor Management's largest Q3 2019 buy was Intuitive Surgical: 705,615 shares worth $127M.
  • HealthCor Management added most to Wright Medical Group Inc in Q3 2019, an estimated $46.7M increase.
  • HealthCor Management's biggest Q3 2019 reduction was Humana, cutting an estimated $161M.
  • HealthCor Management fully exited Elanco Animal Health in Q3 2019, selling an estimated $97.3M.
  • HealthCor Management's ten largest holdings make up 44% of its $2.65B portfolio in Q3 2019.
  • HealthCor Management opened 14 new positions and closed 14 in Q3 2019.
  • HealthCor Management's portfolio value rose 2.6% quarter-over-quarter to $2.65B.

Based on HealthCor Management's 13F filing for Q3 2019, filed 14 Nov 2019.